Details for New Drug Application (NDA): 218002
✉ Email this page to a colleague
The generic ingredient in TAFLUPROST is tafluprost. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the tafluprost profile page.
Summary for 218002
Tradename: | TAFLUPROST |
Applicant: | Ingenus Pharms Llc |
Ingredient: | tafluprost |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.0015% | ||||
Approval Date: | Apr 5, 2024 | TE: | RLD: | No |
Complete Access Available with Subscription